Your browser doesn't support javascript.
loading
Ruxolitinib inhibits IFNγ-stimulated Sjögren's salivary gland MSC HLA-DR expression and chemokine-dependent T cell migration.
McCoy, Sara S; Parker, Maxwell; Gurevic, Ilya; Das, Rahul; Pennati, Andrea; Galipeau, Jacques.
Afiliação
  • McCoy SS; Division or Rheumatology, Department of Medicine, University of Wisconsin School of Medicine and Health.
  • Parker M; Division or Rheumatology, Department of Medicine, University of Wisconsin School of Medicine and Health.
  • Gurevic I; Division or Rheumatology, Department of Medicine, University of Wisconsin School of Medicine and Health.
  • Das R; Department of Medicine, University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI, USA.
  • Pennati A; Department of Medicine, University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI, USA.
  • Galipeau J; Department of Medicine, University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI, USA.
Rheumatology (Oxford) ; 61(10): 4207-4218, 2022 10 06.
Article em En | MEDLINE | ID: mdl-35218354

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glândulas Salivares / Síndrome de Sjogren Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glândulas Salivares / Síndrome de Sjogren Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article